Capricor Therapeutics inc (CAPR) - News Archive

Capricor Therapeutics Makes Strides in Duchenne Muscular Dystrophy Treatment: FDA Meetings and Positive Study Results Propel BLA PathwayCapricor Therapeutics, a biotechnology company specializing in cell and exosome-bas...

Breakthrough in Duchenne Muscular Dystrophy Treatment: Capricor Therapeutics Unveils Promising 3-Year Efficacy Results for CAP-1002 Capricor Therapeutics, a biotech company dedicated to the development of transformative...

Capricor Therapeutics, a pioneering biotechnology firm, is on the verge of revolutionizing medical science with its continuous developments in exosome platform technology, robust manufacturing processes, and strategic c...

aims to provide readers with unbiased and factual information regarding the latest advancements in pharmaceutical research and development. In line with this , this article discusses the recent positive feedback receive...

presents an article summarizing two recent developments by Capricor Therapeutics. The first highlights positive 24-month results from the company s HOPE-2 open-label extension study of CAP-1002 in Duchenne Muscular Dyst...

In recent years, cardiac regenerative therapy has emerged as a promising area of research, with the potential to revolutionize the treatment of heart disorders. Among the frontrunners in this field is Capricor Therapeut...

Capricor Therapeutics Collaborates with National Institutes of Health for Clinical Trial of Novel Exosome-Based Multivalent Vaccine for SARS-CoV-2In recent months, the world has witnessed an unparalleled scientific effo...